A study investigating the clinical course of bronchiectasis after treatment for nontuberculous mycobacterial pulmonary disease

Post-Treatment Evolution of Bronchiectasis in Patients Recovered from NTM pulmonary disease - Post NTM Bronchiectasis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061199

Enrollment

400

Registered

2026-04-08

Start date

2024-12-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received treatment for nontuberculous mycobacterial pulmonary disease at Fukujuji Hospital between January 2006 and Novemnber 2019, achieved microbiological cure, and completed treatment.

Exclusion criteria

Exclusion criteria: HIV positive Patients without bronchiectasis

Design outcomes

Primary

Measure	Time frame
The proportion of patients who develop a chronic bacterial infection.	—

Secondary

Measure	Time frame
The frequency and the risks factors of chronic bacterial infection after the end of NTMPD treatment. The frequency of bronchiectasis exacerbations and radiological changes in patients with chronic infections.	—

Countries

Japan

Contacts

Public ContactMasashi Ito

Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center

masashiito.fj@gmail.com0424914111

Outcome results